AI Insight
The FDA has approved bemotrizinol, the first new sunscreen active ingredient in the United States in over 20 years. Bemotrizinol is a broad-spectrum UV filter that provides enhanced protection against both UVA and UVB radiation, addressing long-standing gaps in American sunscreen formulations compared to those available in Europe and Asia. This approval breaks through decades of regulatory delays that prevented newer, more effective sunscreen technologies from reaching the U.S. market.
Why it matters
This advancement gives American consumers access to superior sun protection that has been available elsewhere for years, potentially reducing skin cancer rates and photoaging. The approval may also pave the way for other modern sunscreen ingredients to enter the U.S. market more efficiently.
Dermatologists and skincare aficionados are excited for the U.S. to finally get a new, more protective sunscreen filter after more than 20 years of regulatory roadblocks. Here’s how bemotrizinol works
Source: How the new FDA-approved ingredient bemotrizinol enhances sunscreen protection